Almaral
VC Fund
Kaarina, Finland
Almaral is a VC fund in Kaarina focused on Medical Device and Health Diagnostics. Almaral provides risk management advice long-term strategy development budgeting operational function setup legal support early-stage sales and marketing function setup, and commercialization.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Almaral invests in
Stages Almaral invests in
Countries Almaral invests in
Round sizes
Round size
- Seed
- $832k–$2.9M
Investment Focus
Industry
- Medical Device 3 (50%)
- Health Diagnostics 2 (33%)
- Software 1 (17%)
- Health Care 1 (17%)
- Gamification 1 (17%)
Stage
- Seed 3 (50%)
- Convertible Note 1 (17%)
- Venture - Series Unknown 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Marginum is a university-based medical technology startup developing fluorescence-based tissue detection systems. The company’s data-driven solutions enable monitoring of tissues during cancer surgery and treatments. The products are derived from state-of-the-art research to improve surgical performance and cost-effectiveness. Marginum’smultidisciplinary team works in close cooperation with academic, clinical and industrial experts to ensure its technological solutions’ seamless clinical compatibility. | $2.9M / Seed / Aug 22, 2025 | ||
| Moncyte Health is developing a patented technology to optimize the treatment and prevention of cardiovascular disease. | $1.1M / Seed / Oct 08, 2024 | ||
| Fepod Oy Ltd develops a point-of-care diagnostics platform for rapid blood concentration measurement of pain medicine and other markers. Using a mobile phone, portable reader, and disposable sensors, it delivers quick, accurate results in minutes, enabling timely treatment decisions in acute care settings. The company aims to be the #1 acute carePOC diagnostics platform by 2030. | $434.3K / Convertible Note / May 31, 2024 | ||
| Marginum is a university-based medical technology startup developing fluorescence-based tissue detection systems. The company’s data-driven solutions enable monitoring of tissues during cancer surgery and treatments. The products are derived from state-of-the-art research to improve surgical performance and cost-effectiveness. Marginum’smultidisciplinary team works in close cooperation with academic, clinical and industrial experts to ensure its technological solutions’ seamless clinical compatibility. | $1.1M / Seed / Nov 10, 2023 | ||
| Lentava Liitutaulu (a.k.a. Seppo) is a Finnish start-up that is specialised in game-based-learning. It has created an interactive platform called Seppo, which allows users to take full advantage of mobile technology and magic of games in corporate training, strategy communication, ESG plan implementation, change management initiatives and beyond.Gamified solutions are versatile and rich – much more than simple quizzes – and encourages the players towards deep analysis, collaboration and self-reflection. The game environment can be e.g. 360 degree picture, 3D world or authentic environment. All this can be done without a single line of code.The solution is powered with artificial intelligence that helps users turn their training or strategy material into an engaging game literally in minutes. Seppo comes with large Content Library of ready made games. The main business model is automated recurring SaaS with ARR of 1 MEUR. | $1.2M / Venture - Series Unknown / Nov 02, 2022 | ||
| Fepod Oy Ltd develops a point-of-care diagnostics platform for rapid blood concentration measurement of pain medicine and other markers. Using a mobile phone, portable reader, and disposable sensors, it delivers quick, accurate results in minutes, enabling timely treatment decisions in acute care settings. The company aims to be the #1 acute carePOC diagnostics platform by 2030. | $831.8K / Seed / May 15, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Almaral invest in?
Almaral invests primarily in Medical Device, Health Diagnostics and Software startups, most often at Seed and Convertible Note stage. Most of the 6 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Almaral's check size?
Almaral typically joins rounds of $832k–$2.9M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Almaral participates in.
When did Almaral last invest?
The most recent investment recorded for Almaral closed in Aug 2025. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
